1-2 of 2
Roberto Massimo Lemoli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Elisa Gelli, Giulia Giorgetti, Claudia Martinuzzi, Francesco Piacente, Dr, Luca Mastracci, Claudia Veneziano, Dr, Gianluca Santamaria, Dr, Fiammetta Monacelli, Moustafa S Ghanem, Antonia Cagnetta, Fabio Guolo, Dr, Matteo Garibotto, Sara Aquino, Mario Passalacqua, Santina Bruzzone, Axel Bellotti, Michel A. Duchosal, Aimable A Nahimana, Emanuele Angelucci, Chandra Nagasuma, Prof, Alessio Nencioni, Roberto Massimo Lemoli, Michele Cea, Prof
Journal: Blood Advances
Blood Adv bloodadvances.2024013425.
https://doi.org/10.1182/bloodadvances.2024013425
Published: 2024
Includes: Supplemental data
Journal Articles

Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS

Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahmé, Sarah Bertoli, Luana Fianchi, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Olivier Legrand, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Leon Caulier, Michelina Dargenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christian Récher, Francesco Grimaldi, Lionel Adès, Roberto Massimo Lemoli
Journal: Blood Advances
Blood Adv bloodadvances.2024014279.
https://doi.org/10.1182/bloodadvances.2024014279
Published: 2024